IMMUNOBIOLOGY OF HYBRID RESISTANCE
IMMUNOBIOLOGY OF HYBRID RESISTANCE
批准号:
6362530
负责人:
Michael Bennett
金额:
$24.37万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-03-01 至 2003-02-28
关键词:
MHC class I antigen T lymphocyte biological signal transduction bone marrow transplantation genetically modified animals homologous transplantation immune tolerance /unresponsiveness laboratory mouse laboratory rabbit laboratory rat natural killer cells passive immunization receptor expression transplant rejection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from Investigator's abstract): The rejection of bone
marrow grafts in mice and other species is mediated largely by natural
killer cells. Although the rejection is highly specific, there is a major
exception to the rules of transplantation genetics, i.e., F1 hybrid mice (or
rats) can reject parental-strain marrow grafts (hybrid resistance). NK
cells lack T or B cell receptor genes that rearrange during development.
Rather, NK cells express receptors for self and other class I antigens; for
the most part, these receptors receive negative signals not to kill target
cells. The major receptor gene family is Ly49, on chromosome 6 near the
NKR-P1 family of NK receptor genes. Both Ly49 and NKR-P1 molecules are type
II integral membrane proteins that exist as homodimers. An immunomodulatory
tyrosine-based inhibitory motif (ITIM) located in the cytoplasmic domain is
responsible for the negative signaling. Two members of the family, Ly49D
and H, lack the ITIM; Ly49D receives activation signals. Co-expression of
Ly49D and a negative signaling Ly49 receptor should not kill because the
negative signal dominates. The goal of this proposal is to determine how
these NK cell receptors regulate rejection of marrow grafts. Aim 1:
Determine the role of Ly49C and Ly49I NK cell receptors in rejection of
incompatible marrow grafts. Two hypotheses to test: 1) the allelic forms
of ITIM+ Ly49C and Ly49I receptors and class I antigens are both critical
for the ability of NK cells of various strains to recognize target cells;
this ability is also regulated by selective use of these genes; 2)
expression of Ly49I gene of B6 mice as a transgene can alter the ability of
mice to reject marrow grafts. Aim 2: Determine the mechanism by which the
ITIM- Ly49D subsets of NK cells reject marrow grafts differing by particular
class I antigens. Two hypotheses to test: 1) the allelic form of Ly49D
will regulate the ability of NK cells to reject class I allogeneic marrow
grafts. Transfer of the Ly49D gene of B6 to FVB mice that are "poor
rejectors" will endow them with the ability to reject such marrow grafts; 2)
Ly49D NK cells develop "tolerance" to self class I antigens during
development by co-expressing ITIM+ Ly49 receptors that also recognize the
self antigen. Aim 3: Analyze the mechanisms by which Ly49- NK cells fail
to reject allogeneic marrow grafts. Two hypotheses to test: 1) Ly49- NK
cells receive negative signals from most class I Ags on marrow cells; 2)
non-Ly49 receptors of NK cells, e.g., NKR-P1B (10A7), that are ITIM+ are
lacking on Ly49+ cells except for those that do not recognize "self" class
I.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-canonical mechanisms of excitotoxicity
-
批准号:10679904
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2023
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:6376235
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2000
-
负责人:Michael Bennett
-
依托单位:
PATHOLOGY UTSWMC
-
批准号:6340695
-
项目类别:
-
资助金额:$12.43万
-
财政年份:2000
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:6633105
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2000
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:6131639
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2000
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:6512815
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2000
-
负责人:Michael Bennett
-
依托单位:
INTERNATIONAL CONFERENCE ON THE CEROID-LIOPFUSCINOSES
-
批准号:2723292
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1998
-
负责人:Michael Bennett
-
依托单位:
TOLERANCE TO BONE MARROW TRANSPLANTS
-
批准号:6100018
-
项目类别:
-
资助金额:$16.25万
-
财政年份:1998
-
负责人:Michael Bennett
-
依托单位:
TOLERANCE TO BONE MARROW TRANSPLANTS
-
批准号:6235437
-
项目类别:
-
资助金额:$15.62万
-
财政年份:1997
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:2114084
-
项目类别:
-
资助金额:$17.78万
-
财政年份:1996
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:2390914
-
项目类别:
-
资助金额:$18.3万
-
财政年份:1996
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:2683639
-
项目类别:
-
资助金额:$18.84万
-
财政年份:1996
-
负责人:Michael Bennett
-
依托单位:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
-
批准号:2895496
-
项目类别:
-
资助金额:$19.37万
-
财政年份:1996
-
负责人:Michael Bennett
-
依托单位:
PATHOLOGY UTSWMC
-
批准号:6212451
-
项目类别:
-
资助金额:$12.43万
-
财政年份:1995
-
负责人:Michael Bennett
-
依托单位:
BATTEN DISEASE, MEMBRANE LIPIDS AND SIGNAL TRANSDUCTION
-
批准号:3417105
-
项目类别:
-
资助金额:$8.03万
-
财政年份:1992
-
负责人:Michael Bennett
-
依托单位:
BATTEN DISEASE, MEMBRANE LIPIDS AND SIGNAL TRANSDUCTION
-
批准号:2268225
-
项目类别:
-
资助金额:$8.92万
-
财政年份:1992
-
负责人:Michael Bennett
-
依托单位:
BATTEN DISEASE, MEMBRANE LIPIDS AND SIGNAL TRANSDUCTION
-
批准号:3417103
-
项目类别:
-
资助金额:$11.18万
-
财政年份:1992
-
负责人:Michael Bennett
-
依托单位:
IMMUNOGENETICS OF HYBRID RESISTANCE
-
批准号:2089197
-
项目类别:
-
资助金额:$25.77万
-
财政年份:1984
-
负责人:Michael Bennett
-
依托单位:
IMMUNOBIOLOGY OF HYBRID RESISTANCE
-
批准号:2089200
-
项目类别:
-
资助金额:$19.26万
-
财政年份:1984
-
负责人:Michael Bennett
-
依托单位:
IMMUNOGENETICS OF HYBRID RESISTANCE
-
批准号:3174577
-
项目类别:
-
资助金额:$8.79万
-
财政年份:1984
-
负责人:Michael Bennett
-
依托单位:
海外基金